CDH2 and endometrial cancer: Our data demonstrate that targeting Twist and N-cadherin with a GHRH antagonist blocked Twist and N-cadherin-induced cell migration and invasion, specifying that the actions of a GHRH antagonist in endometrial cancer cells are highly associated with Twist and N-cadherin expression.